/Not yet recruitingN/A Long-term Follow-up Study of BRL-101 in the Treatment of Transfusion-dependent β-thalassemia Observe long-term safety risk and long-term efficacy after intravenous infusion of BRL-101 in TDT subjects. 开始日期2024-12-08 申办/合作机构 上海邦耀生物科技有限公司 [+6]...